Molecular Diversity of Hydroxamic Acids: Part II. Potential Therapeutic Applications

被引：30

作者：

Lou, Boliang ^{[1
]}

Yang, Kexin ^{[1
]}

机构：

[1] Adv SynTech, Louisville, KY 40299 USA

来源：

MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2003年 / 3卷 / 06期

关键词：

D O I：

10.2174/1389557033487872

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A hydroxamic acid moiety has been demonstrated as the key structural element in many highly potent and selective inhibitors against a variety of metalloprotease enzymes, such as MMPs, TACE, HDAC, PDF, etc. Over the last several years, there has been a rapid growth of literature and patent applications dealing with the development of the hydroxamic acid-based inhibitors. This review highlights the most recent examples to show their potential therapeutic applications.

引用

页码：609 / 620

页数：12

共 94 条

[91] Molecular Diversity of Hydroxamic Acids: Part I. Solution- and Solid-Phase Synthesis [J].

Yang, Kexin ;

Lou, Boliang .

MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2003, 3 (04) :349-360

[92] Design and synthesis of a series of (2R)-N4-hydroxy-2-(3-hydroxybenzyl)-N1-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors [J].

Yao, WQ ;

Wasserman, ZR ;

Chao, M ;

Reddy, G ;

Shi, E ;

Liu, RQ ;

Covington, MB ;

Arner, EC ;

Pratta, MA ;

Tortorella, M ;

Magolda, RL ;

Newton, R ;

Qian, MX ;

Ribadeneira, MD ;

Christ, D ;

Wexler, RR ;

Decicco, CP .

JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (21) :3347-3350

[93]

Yong VW, 1998, TRENDS NEUROSCI, V21, P75

[94]

YOSHIDA M, 1990, J BIOL CHEM, V265, P17174

← 1 2 3 4 5 6 7 8 9 10 →